相关实验视频
Updated: Sep 10, 2025

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.6K
亚细胞Argonaute 2在心血管疾病中的作用
Yifan Cai1, Weijian Hang1,2, Rong Xie1,2
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Journal of translational internal medicine
|August 27, 2025
概括
阿尔戈纳特2 (Ago2) 蛋白调节基因表达. 新兴研究表明核和线粒体Ago2参与心血管疾病,这表明高血压和心力衰竭等疾病的新治疗点.
科学领域:
- 分子生物学
- 心血管研究
- 基因调控
背景情况:
- 阿尔戈纳特2 (Ago2) 是微RNA诱导沉默复合体 (miRNA-RISC) 中介的基因调控的核心.
- 传统上,Ago2 在细胞质中以后的转录方式发挥作用,影响信使RNA (mRNA) 的转化.
- 最近的研究显示Ago2的转移到核和线粒体.
研究的目的:
- 审查哺乳动物Ago2传输机制进入亚细胞器官.
- 总结Ago2在心血管疾病中的作用和分子机制.
- 为Ago2提供针对心血管治疗的框架.
主要方法:
- 对Ago2亚细胞局部化的最新研究的文献综述.
- 对Ago2运输的分子机制的分析.
- 对Ago2在心血管病理中的作用的综合发现.
主要成果:
- 在核和线粒体中越来越多地发现ago2.
- 核和线粒体Ago2与包括高血压,糖尿病心肌病和心力衰竭在内的心血管疾病有关.
- 这些亚细胞作用表明了新的治疗途径.
结论:
- 在细胞质之外,Ago2的亚细胞本地化对于其功能至关重要.
- 针对核和线粒体Ago2为心血管疾病提供了一个有前途的治疗策略.
- 需要对Ago2的传输和功能进行进一步的研究,以开发新的治疗方法.
相关概念视频
Regulation of the Cardiovascular System
1.8K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.8K
Coronary Artery Disease II: Pathophysiology
34
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55

